Health Catalyst, Inc.

NASDAQ:HCAT

Medical - Healthcare Information Services

Healthcare
$1.29 -1.98%

-$0.04 today

Market cap
$98.24M
Beta
1.66
P/E (TTM)
-0.5
EPS (TTM)
-$3.65
52W Low $0.96High $4.13

Volume 0.27M

Average 1.24M

HCAT Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Health Catalyst, Inc.NASDAQ: HCAT

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 72.59M shares rose 5.9% year over year, behind the +13.1% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 2.2% from the prior quarter. Over 3 fiscal years it compounded at +9.2% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +5.9% toward the trailing-twelve-month pace of +13.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
72.59M+2.2% QoQ
Last fiscal yearDec 2025
69.9M+16.1% YoY
LTMMar 2026
70.9M+13.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.9%——
1 year+16.1%——
3-year CAGR+9.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
69.9M USD
Year-over-year change
+16.1%
4-year CAGR
+10.1%

Weighted Avg Shares vs competitors

How HCAT compares with its peers on the latest reported figures

  • HCAT's LTM Mar 2026 weighted avg shares of 70.9M shares is the 4th highest of the 11 companies compared; the peer median is 50.46M shares.
  • Its year-over-year change of +13.1% is the 5th highest of 11, against a peer median of +7.0%.
  • Over three fiscal years its annual growth of +9.2% compares with a peer median of +20.5%.
HCAT Competitors Peer median
Weighted Avg Shares for HCAT and competitors
Company Period LTM YoY 3-year CAGR
TNYATenaya Therapeutics, Inc.LTM Mar 2026158.02M +71.7%+50.6%
CRBUCaribou Biosciences, Inc.LTM Mar 202694.18M +3.6%+15.4%
PRLDPrelude Therapeutics IncorporatedLTM Mar 202674.4M -1.9%+17.6%
HCATHealth Catalyst, Inc.LTM Mar 202670.9M +13.1%+9.2%
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
PYXSPyxis Oncology, Inc.LTM Mar 202662.52M +2.9%+23.4%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 202638.39M +2.6%+14.7%
HSDTSolana CompanyLTM Mar 202625.93M +788.1%+244.4%
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 202621.37M +0.6%+1.2%
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
SNWVSANUWAVE Health, Inc.LTM Mar 20268.57M +83.3%+80.1%
Peer median (excluding HCAT) 50.46M+7.0%+20.5%

Competitors are the stored peer set for HCAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue241.93M276.24M295.94M306.58M311.14M
Cost of Revenue124.35M143.05M164.11M165.81M207M
Gross Profit117.57M133.19M131.83M140.78M104.13M
Gross Margin48.6%48.2%44.5%45.9%33.5%
Research & Development62.73M75.68M72.63M57.95M49.77M
Selling, General & Admin160.96M149.22M143.88M111.2M102.04M
Operating Expenses261.22M273.19M258.73M210.59M140.24M
Depreciation & Amortization41.11M51.53M42.22M41.43M50.5M
EBITDA(101.68M)(82.92M)(68.28M)(10.65M)(110.35M)
EBITDA Margin-42.0%-30.0%-23.1%-3.5%-35.5%
Operating Income(143.65M)(140.01M)(126.9M)(69.81M)(36.1M)
Operating Margin-59.4%-50.7%-42.9%-22.8%-11.6%
Interest Income831K5.69M16.39M17.98M7.54M
Interest Expense17.31M7.24M7.29M17.09M16.4M
Other Income / Expenses(16.46M)(1.68M)9.11M637K(141.15M)
Income Before Tax(160.11M)(141.68M)(117.79M)(69.17M)(177.26M)
Pre-Tax Margin-66.2%-51.3%-39.8%-22.6%-57.0%
Income Tax Expense(6.9M)(4.28M)356K333K716K
Net Income(153.21M)(137.4M)(118.15M)(69.5M)(177.97M)
Net Margin-63.3%-49.7%-39.9%-22.7%-57.2%
EPS (Basic)(3.23)(2.56)(2.09)(1.15)(2.55)
EPS (Diluted)(3.23)(2.54)(2.09)(1.15)(2.55)
Weighted Avg Shares47.49M53.72M56.42M60.19M69.9M
Weighted Avg Shares (Diluted)47.49M54.08M56.42M60.19M69.9M

Health Catalyst, Inc.

NASDAQ:HCAT

Intrinsic Alpha fair value

Locked

Current Price

$1.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.